Nova Eye Medical Stock Current Liabilities
| EYE Stock | 0.18 0.01 5.26% |
Nova Eye Medical fundamentals help investors to digest information that contributes to Nova Eye's financial success or failures. It also enables traders to predict the movement of Nova Stock. The fundamental analysis module provides a way to measure Nova Eye's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nova Eye stock.
Total Current Liabilities is likely to gain to about 9.4 M in 2025, whereas Non Current Liabilities Total is likely to drop slightly above 2.1 M in 2025. Nova | Current Liabilities |
Nova Eye Medical Company Current Liabilities Analysis
Nova Eye's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
Nova Total Current Liabilities
Total Current Liabilities |
|
In accordance with the recently published financial statements, Nova Eye Medical has a Current Liabilities of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The current liabilities for all Australia stocks is 100.0% higher than that of the company.
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Nova Fundamentals
| Return On Equity | -0.39 | ||||
| Return On Asset | -0.19 | ||||
| Profit Margin | (0.38) % | ||||
| Operating Margin | (0.26) % | ||||
| Current Valuation | 40.72 M | ||||
| Shares Outstanding | 229.07 M | ||||
| Shares Owned By Insiders | 18.59 % | ||||
| Shares Owned By Institutions | 18.74 % | ||||
| Price To Book | 2.04 X | ||||
| Price To Sales | 1.77 X | ||||
| Revenue | 23.32 M | ||||
| Gross Profit | 14.39 M | ||||
| EBITDA | (5.98 M) | ||||
| Net Income | (8.79 M) | ||||
| Cash And Equivalents | 7.42 M | ||||
| Total Debt | 3.35 M | ||||
| Book Value Per Share | 0.09 X | ||||
| Cash Flow From Operations | (7.73 M) | ||||
| Earnings Per Share | (0.04) X | ||||
| Target Price | 0.59 | ||||
| Beta | 0.96 | ||||
| Market Capitalization | 41.23 M | ||||
| Total Asset | 29.88 M | ||||
| Retained Earnings | (30.69 M) | ||||
| Working Capital | 9.07 M | ||||
| Net Asset | 29.88 M |
About Nova Eye Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nova Eye Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nova Eye using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nova Eye Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nova Stock Analysis
When running Nova Eye's price analysis, check to measure Nova Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Eye is operating at the current time. Most of Nova Eye's value examination focuses on studying past and present price action to predict the probability of Nova Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Eye's price. Additionally, you may evaluate how the addition of Nova Eye to your portfolios can decrease your overall portfolio volatility.